These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36761145)

  • 41. Factors influencing COVID-19 vaccine acceptance and hesitancy among rural community in Bangladesh: A cross-sectional survey based study.
    Roy DN; Huda MN; Azam MS
    Hum Vaccin Immunother; 2022 Nov; 18(5):2064685. PubMed ID: 35580319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
    Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
    JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors Associated with COVID-19 Vaccine Acceptance among Healthcare Professionals and Community Stakeholders in Hong Kong: A Cross-Sectional Study.
    Lee RLT; Chien WT; Stubbs M; Cheng WLS; Chiu DCS; Fung KHK; Cheng HY; Chong YY; Tang ACY
    Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COVID-19 vaccine hesitancy and related fears and anxiety.
    Bendau A; Plag J; Petzold MB; Ströhle A
    Int Immunopharmacol; 2021 Aug; 97():107724. PubMed ID: 33951558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK.
    Walsh JC; Comar M; Folan J; Williams S; Kola-Palmer S
    Acta Psychol (Amst); 2022 May; 225():103550. PubMed ID: 35259642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamic Trends and Underlying Factors of COVID-19 Vaccine Booster Hesitancy in Adults: Cross-Sectional Observational Study.
    Wu J; Ma M; Li Q; Guo X; Tarimo CS; Jia S; Zhou X; Wang M; Gu J; Miao Y; Ye B
    JMIR Public Health Surveill; 2023 Aug; 9():e44822. PubMed ID: 37526963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. When to be vaccinated? What to consider? Modelling decision-making and time preference for COVID-19 vaccine through a conjoint experiment.
    Yue PHR; Lau HPB; Ng SM; Chan LWC; Yuen S
    Vaccine; 2023 Oct; 41(42):6300-6308. PubMed ID: 37679277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients.
    Wang T; Bai Y; Bai L; Wang N
    Medicine (Baltimore); 2023 Jun; 102(26):e33923. PubMed ID: 37390289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.
    Ehde DM; Roberts MK; Humbert AT; Herring TE; Alschuler KN
    Mult Scler Relat Disord; 2021 Sep; 54():103163. PubMed ID: 34325399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.
    Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J
    Front Public Health; 2022; 10():986916. PubMed ID: 36589991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 Vaccine Hesitancy in a Medically-Challenged Context: A Cross-Sectional Study of Drivers, Dangers and Corrective Measures for Vaccine Hesitancy and Potential Penalties for Declining Vaccination among Adults in South-Eastern Nigeria.
    Iloh GU; Chukwuonye ME
    West Afr J Med; 2022 Sep; 39(9):889-895. PubMed ID: 36116070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Large and small financial incentives may motivate COVID-19 vaccination: A randomized, controlled survey experiment.
    Fishman J; Mandell DS; Salmon MK; Candon M
    PLoS One; 2023; 18(3):e0282518. PubMed ID: 36930588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using message framing to promote acceptance of the human papillomavirus vaccine.
    Gerend MA; Shepherd JE
    Health Psychol; 2007 Nov; 26(6):745-52. PubMed ID: 18020847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COVID-19 vaccine preferences among university students in Hong Kong: a discrete choice experiment.
    Li X; Chong MY; Chan CY; Chan VWS; Tong X
    BMC Res Notes; 2021 Nov; 14(1):421. PubMed ID: 34809681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leveraging 13 million responses to the U.S. COVID-19 Trends and Impact Survey to examine vaccine hesitancy, vaccination, and mask wearing, January 2021-February 2022.
    Nguyen QC; Yardi I; Gutierrez FXM; Mane H; Yue X
    BMC Public Health; 2022 Oct; 22(1):1911. PubMed ID: 36229804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Efficacy of a Brief, Altruism-Eliciting Video Intervention in Enhancing COVID-19 Vaccination Intentions Among a Population-Based Sample of Younger Adults: Randomized Controlled Trial.
    Zhu P; Tatar O; Griffin-Mathieu G; Perez S; Haward B; Zimet G; Tunis M; Dubé È; Rosberger Z
    JMIR Public Health Surveill; 2022 May; 8(5):e37328. PubMed ID: 35544437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behavioral intention and its predictors toward COVID-19 vaccination among people most at risk of exposure in Ethiopia: applying the theory of planned behavior model.
    Asmare G; Abebe K; Atnafu N; Asnake G; Yeshambel A; Alem E; Chekol E; Asmamaw T
    Hum Vaccin Immunother; 2021 Dec; 17(12):4838-4845. PubMed ID: 35213947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study.
    Roy DN; Azam MS; Islam E
    PLoS One; 2023; 18(4):e0281395. PubMed ID: 37053270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers.
    Miner CA; Timothy CG; Percy K; Mashige ; Osuagwu UL; Envuladu EA; Amiebenomo OM; Ovenseri-Ogbomo G; Charwe DD; Goson PC; Ekpenyong BN; Abu EK; Langsi R; Oloruntoba R; Ishaya T; Agho KE
    BMC Public Health; 2023 Jan; 23(1):191. PubMed ID: 36709269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China.
    Wang J; Yuan B; Lu X; Liu X; Li L; Geng S; Zhang H; Lai X; Lyu Y; Feng H; Jing R; Guo J; Huang Y; Liang X; Yu W; Fang H
    Hum Vaccin Immunother; 2021 Dec; 17(12):4873-4888. PubMed ID: 34906026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.